D.C.’s New Crime Lab Goes Under the Microscope
By Editorial,
Washington Post Editorial
| 03. 11. 2015
WHAT’S THE point of spending millions of dollars on a crime lab if people don’t trust its findings and won’t use it? That is one question D.C. officials should be asking in light of the unsettling revelation that the U.S. Attorney’s Office has stopped sending DNA evidence to the new Consolidated Forensic Laboratory because it claims there have been serious mistakes. Far more than money is at issue: Forensics plays a key role in determining the guilt or innocence of crime suspects. The concerns of federal prosecutors must be investigated and the integrity of the lab assured.
In January federal prosecutors stopped sending evidence for DNA testing to the crime lab, which is operated by the District’s Department of Forensic Sciences, opting instead to pay for tests at outside labs. The move, as The Post’s Keith L. Alexander reported, came after an outside expert, in a routine review of evidence for an upcoming case, found errors in the interpretation of test results; a subsequent review of 116 cases by two nationally known experts found what federal prosecutors characterized as...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...